Compare HALO & GVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HALO | GVA |
|---|---|---|
| Founded | 1998 | 1922 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Military/Government/Technical |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 6.6B |
| IPO Year | 2001 | 1995 |
| Metric | HALO | GVA |
|---|---|---|
| Price | $74.99 | $160.15 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 3 |
| Target Price | $78.64 | ★ $118.33 |
| AVG Volume (30 Days) | ★ 1.6M | 733.9K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.42% |
| EPS Growth | N/A | ★ 47.33 |
| EPS | ★ 1.22 | N/A |
| Revenue | $151,862,000.00 | ★ $1,762,965,000.00 |
| Revenue This Year | $28.24 | $13.26 |
| Revenue Next Year | $12.56 | $6.92 |
| P/E Ratio | $59.53 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $51.06 | $89.80 |
| 52 Week High | $82.22 | $157.54 |
| Indicator | HALO | GVA |
|---|---|---|
| Relative Strength Index (RSI) | 66.87 | 76.40 |
| Support Level | $62.53 | $116.73 |
| Resistance Level | $79.50 | N/A |
| Average True Range (ATR) | 2.20 | 4.73 |
| MACD | 0.30 | 1.69 |
| Stochastic Oscillator | 84.09 | 98.07 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Granite Construction Inc engages in the construction and development of various infrastructure projects on behalf of public and private clients in the United States. The company focuses on heavy civil infrastructure projects, including roads, highways, transit facilities, airports, bridges, dams, tunnels, and other infrastructure projects. In addition, the company performs site preparation and infrastructure services for residential development, energy development, and other facilities. The majority of revenue is derived from the company's Construction operating segment, and rest from Materials segment.